IRAE
Clinical trials for IRAE explained in plain language.
Never miss a new study
Get alerted when new IRAE trials appear
Sign up with your email to follow new studies for IRAE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to fix Immunotherapy's blood problems in lung cancer
Disease control Not yet recruitingThis phase 2 trial tests the drug golidocitinib in 16 people with advanced lung cancer who have severe blood problems caused by immunotherapy. The goal is to see if the drug can safely improve blood counts and reduce symptoms. Participants take the drug until their blood levels r…
Matched conditions: IRAE
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Common nausea pill may tame immunotherapy's harsh side effects in liver cancer
Symptom relief Not yet recruitingThis study tests whether ondansetron, a drug typically used for nausea, can lower the risk and severity of side effects from immunotherapy in people with liver cancer. About 134 patients will receive ondansetron alongside their standard cancer treatment. The goal is to see if thi…
Matched conditions: IRAE
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC